GlobeNewswire Inc | Sep 2, 2021 08:00AM EDT

September 02, 2021

NORTH BILLERICA, Mass., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc.(NASDAQ: LNTH) (Lantheus), an established leader and fully integrated provider committed to innovative imaging diagnostics, targeted therapeutics and artificial intelligence solutions to find, fight and follow serious medical conditions, today announced Mary Anne Heino, President and Chief Executive Officer, and Bob Marshall, Chief Financial Officer and Treasurer, will present at the following investor conferences.

-- Wells Fargo 2021 Virtual Healthcare ConferenceSeptember 9, 2021 at 4 p.m. ET

-- Baird 2021 Global Healthcare ConferenceSeptember 15, 2021 at 7:55 a.m. ET

To access a live webcast of the presentation, please visit theInvestors section of the Companys website at www.lantheus.com. A replay of the webcast will be available on the Companys website for 30 days following the live presentation.

About Lantheus Holdings, Inc. Lantheus Holdings, Inc. is the parent company of Lantheus Medical Imaging, Inc., Progenics Pharmaceuticals, Inc. and EXINI Diagnostics AB and an established leader and fully integrated provider committed to innovative imaging diagnostics, targeted therapeutics and artificial intelligence solutions to Find Fight and Follow serious medical conditions. Lantheus provides a broad portfolio of products, including the echocardiography agent DEFINITY Vial for (Perflutren Lipid Microsphere) Injectable Suspension; PYLARIFY, a PSMA PET imaging agent for the detection of suspected recurrent or metastatic prostate cancer; TechneLite (Technetium Tc99m Generator), a technetium-based generator that provides the essential medical isotope used in nuclear medicine procedures; AZEDRA for the treatment of certain rare neuroendocrine tumors; and RELISTOR for the treatment of opioid-induced constipation, which is partnered with Bausch Health Companies, Inc. The Company is headquartered in North Billerica, Massachusetts with offices in New York, New Jersey, Canada and Sweden. For more information, visit www.lantheus.com.

Contacts:Mark KinarneySenior Director, Investor Relations978-671-8842ir@lantheus.com

Melissa Downs Director, Corporate Communications646-975-2533media@lantheus.com